THThomas Hillemacher

Thomas Hillemacher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Hillemacher has a total of 83 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Systematic Review and Meta-Analysis of Cognitive Effects of rTMS in Caucasian Patients with Mild Cognitive Impairment

    by Christiane Licht, Swetlana Herbrandt, Carmen van Meegen, Hartmut Lehfeld, Thomas Hillemacher, Kneginja Richter

    In recent years, repetitive transcranial magnetic stimulation (rTMS) has received much attention as a non-invasive, effective treatment modality for mild cognitive impairment (MCI). Although several meta-analyses have reported that rTMS can improve cognitive abilities, improvements in individual memory domains (speech, language, concentration, and memory) are poorly understood. In addition, stimulation parameters may be flawed in studies of global populations because of ethnic differences between Caucasians and Asians. This meta-analysis aimed to systematically characterize the efficacy of different combinations of rTMS parameters on different cognitive domains in Caucasian patients with MCI. We conducted a systematic literature search in Medline PubMed, Pubpsych, and Embase on the use of rTMS in MCI patients through November 2022. Randomized, double-blind, and sham-controlled trials (RCTs) from the Caucasian patient population were included. The studies reported outcome measures for different domains of cognition, such as language, concentration, or memory. Possible effects of covariates were examined using meta-regressions. The search yielded five publications. The analyses found that rTMS improved cognitive functions, memory, concentration, and language in patients with MCI and treatment with rTMS compared with the sham stimulation group. The statistical analysis results of the studies showed that rTMS could improve various cognitive functions, such as memory and concentration, in Caucasian MCI patients. A particular effect was found at a frequency of 10 Hz and stimulation of the LDLPFC. However, further studies are needed to validate these findings and explore more effective stimulation protocols and targets.


  • Psychometric properties of the German Penn Alcohol Craving Scale

    by Helmut Nakovics, Sabine Hoffmann, Anne Koopmann, Patrick Bach, Martin Abel, Wolfgang H Sommer, Falk Kiefer, Christian Weinland, Claudia von Zimmermann, Eva-Maria Siegmann, et al.

    Craving for alcohol is an important diagnostic criterion in alcohol use disorder (AUD) and an established predictor of future relapse. The 5-item Penn Alcohol Craving Scale (PACS) is one of the most widely used questionnaires to quantify craving and has been translated into different languages. It is assumed that the PACS constitutes one factor, although theoretical considerations suggest an additional second factor. We conducted stability and factor analyses (principal component and confirmatory factor analyses) of the German PACS (PACS-G) in samples of patients with AUD from the following three German study sites: Erlangen, N = 188 (mean age: 47.1 years, 43.5% female); Mannheim, N = 440 (45.5 years, 28.6% female); Hannover, N = 107 (48.1 years, 48.6% female). In our samples, the 2-factor solution of the PACS-G version is more stable than the internationally assumed 1-factor solution. The resulting two PACS-G subscores ‘difficulty to resist’ (items 4 and 5) and ‘thoughts about alcohol’ (items 1, 2, and 3) have an internal consistency (Cronbach’s alpha) of 0.80 ≤ α ≤ 0.90, m = 0.86 and 0.86 ≤ α ≤ 0.91, m = 0.89 with an overlap of R2 = 62%. We found good convergent validity assessed via the Craving Automatized Scale-Alcohol and the Obsessive-Compulsive Drinking Scale, but also correlations with depression and anxiety assessed via the Beck’s Depression and Anxiety Inventories. This study is the first to provide evidence for a 2-factor solution (‘difficulty to resist’ and ‘thoughts about alcohol’) underlying the PACS-G version.


  • Combination Therapies and Switching of Agents in Depression and Bipolar Disorders

    by Thorsten Folsche, Hannah Benedictine Maier, Thomas Hillemacher, Helge Frieling

  • Open Access

    The Relationship of Shopping-Related Decisions with Materialistic Values Endorsement, Compulsive Buying-Shopping Disorder Symptoms and Everyday Moral Decision Making

    by Astrid Müller, Ekaterini Georgiadou, Annika Birlin, Nora M. Laskowski, Susana Jiménez-Murcia, Fernando Fernández-Aranda, Thomas Hillemacher, Martina de Zwaan, Matthias Brand, Sabine Steins-Loeber

    Background: Compulsive buying-shopping disorder (CBSD) is associated with high materialistic values endorsement and excessive purchasing of consumer goods. A subgroup of individuals with CBSD engage in socially unacceptable behaviors to continue shopping despite negative consequences. This investigation aimed at exploring possible links between ego-oriented shopping-related decisions, materialism, symptoms of CBSD and close-to-everyday moral decision making. Methods: In study 1, patients with CBSD were interviewed to develop a list of conflict situations, capturing typical shopping-related dilemmas. In study 2, the shopping-related dilemmas from study 1, standardized close-to-everyday moral dilemmas, the Material Values Scale and Pathological Buying Screener were administered to a web-based convenience sample (n = 274). Results: The main effects of a moderated hierarchical regression analysis revealed an association of more ego-oriented shopping-related decisions with both higher materialistic values endorsement and more CBSD symptoms, but not with everyday moral decision-making. However, a more egoistic everyday moral decision making style moderated the effect of CBSD symptoms on ego-oriented shopping related decisions. Conclusions: The findings indicate that a more egoistic everyday moral decision making style is not directly linked to domain-specific shopping-related decision making but strengthens the link between symptoms of CBSD and ego-oriented shopping-related decisions.


  • Open Access

    Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine

    by Kneginja Richter, Stefanie Kellner, Thomas Hillemacher, Olga Golubnitschaja

    Sleep quality and duration play a pivotal role in maintaining physical and mental health. In turn, sleep shortage, deprivation and disorders are per evidence the risk factors and facilitators of a broad spectrum of disorders, amongst others including depression, stroke, chronic inflammation, cancers, immune defence insufficiency and individual predisposition to infection diseases with poor outcomes, for example, related to the COVID-19 pandemic. Keeping in mind that COVID-19-related global infection distribution is neither the first nor the last pandemic severely affecting societies around the globe to the costs of human lives accompanied with enormous economic burden, lessons by predictive, preventive and personalised (3P) medical approach are essential to learn and to follow being better prepared to defend against global pandemics. To this end, under extreme conditions such as the current COVID-19 pandemic, the reciprocal interrelationship between the sleep quality and individual outcomes becomes evident, namely, at the levels of disease predisposition, severe versus mild disease progression, development of disease complications, poor outcomes and related mortality for both - population and healthcare givers. The latter is the prominent example clearly demonstrating the causality of severe outcomes, when the long-lasting work overload and shift work rhythm evidently lead to the sleep shortage and/or deprivation that in turn causes immune response insufficiency and strong predisposition to the acute infection with complications. This article highlights and provides an in-depth analysis of the concerted risk factors related to the sleep disturbances under the COVID-19 pandemic followed by the evidence-based recommendations in the framework of predictive, preventive and personalised medical approach.


  • Combination Therapies and Switching of Agents in Depression and Bipolar Disorders

    by Thorsten Folsche, Hannah Benedictine Maier, Thomas Hillemacher, Helge Frieling

  • Open Access

    Insomnia Associated with Tinnitus and Gender Differences

    by Kneginja Richter, Melanie Zimni, Iva Tomova, Lukas Retzer, Joachim Höfig, Stefanie Kellner, Carla Fries, Karina Bernstein, Wolfgang Hitzl, Thomas Hillemacher, et al.

    Chronic tinnitus causes a decrease in well-being and can negatively affect sleep quality. It has further been indicated that there are clinically relevant gender differences, which may also have an impact on sleep quality. By conducting a retrospective and explorative data analysis for differences in patients with tinnitus and patients diagnosed with tinnitus and insomnia, hypothesized differences were explored in the summed test scores and on item-level of the validated psychometric instruments. A cross-sectional study was conducted collecting data from a sample of tinnitus patients (n = 76). Insomnia was diagnosed in 49 patients. Gender differences were found on aggregated test scores of the MADRS and BDI with men scoring higher than women, indicating higher depressive symptoms in men. Women stated to suffer more from headaches (p < 0.003), neck pain (p < 0.006) and nervousness as well as restlessness (p < 0.02). Women also reported an increase in tinnitus loudness in response to stress compared to men (p < 0.03). Male individuals with tinnitus and insomnia have higher depression scores and more clinically relevant depressive symptoms than women, who suffer more from psychosomatic symptoms. The results indicate a need for a targeted therapy of depressive symptoms in male patients and targeted treatment of psychosomatic symptoms, stress-related worsening of insomnia and tinnitus in women.


  • Internalizing and externalizing subtypes in female patients with co-occurring post-traumatic stress disorder and substance use disorders

    by Naily Raj, Uwe Verthein, Johanna Grundmann, Annett Lotzin, Philipp Hiller, Bernd Schulte, Martin Driessen, Thomas Hillemacher, Norbert Scherbaum, Martin Schäfer, et al.


  • Open Access

    COVID-19 Lockdown Restrictions and Online Media Consumption in Germany

    by Tagrid Lemenager, Miriam Neissner, Anne Koopmann, Iris Reinhard, Ekaterini Georgiadou, Astrid Müller, Falk Kiefer, Thomas Hillemacher

    The lockdown restrictions due to the COVID-19 pandemic have led to increased stress levels and feelings of anxiety in the general population. Problematic usage of certain online applications is one frequent way to compensate for negative feelings and stress. The current study investigated changes of online media consumption during the lockdown in Germany. Gender and age specific differences in specific online activities were assessed. n = 3245 subjects participated in an online survey conducted between the 8th April and the 11th May 2020. Participants’ age ranged between 18 and >55 years. A considerably high percentage (71.4%) of participants reported increased online media consumption during the lockdown. Male participants were more likely to increase their consumption of gaming and erotic platforms, while female participants reported a higher increase in the engagement in social networks, information research, and video streaming than males. The findings revealed an increased usage of all online applications during the lockdown. For the clarification whether the increase might present a risk for elevated Internet-use disorders or can be regarded as a functional and time-limited phenomenon, further studies, assessing changes in these online activities after the end of the pandemic, are needed.


  • Antipsychotika in der Schwangerschaft: eine systematische Übersichtsarbeit

    by Thomas Hillemacher, Susanne Simen, Marie-Kathrin Rehme, Helge Frieling

    Zusammenfassung Hintergrund Nutzen und Risiken der Behandlung mit Antipsychotika während der Schwangerschaft müssen sorgfältig und individuell abgewogen werden, da Antipsychotika die Plazentaschranke durchdringen können und eine Verordnung off-label ist Fragestellung Bei der Behandlung von Frauen im gebärfähigen Alter stellen sich insbesondere Fragen zur Teratogenität, zum Risiko für Fehl- und Totgeburten sowie zu perinatalen Komplikationen und postnatal anhaltenden Störungen, aber auch z. B. Schwangerschaftsdiabetes? Methode Es wird ein systematischer Literaturüberblick gegeben, der eine Hilfe bei der Auswahl von Psychopharmaka in der Schwangerschaft bieten soll und bei der Entscheidung darüber, ob eine antipsychotische Behandlung, die bei Schwangerschaft begonnen, fortgesetzt oder umgestellt wird, Unterstützung bietet. Ergebnisse Große, gut angelegte und kontrollierte Studien fehlen. Ein Großteil der Studien deutet aber darauf hin, dass die Gruppe der Antipsychotika in Bezug auf Teratogenität in der Schwangerschaft zumindest in Monotherapie sicher zu sein scheint. Schlussfolgerungen Bei der Behandlung psychischer Erkrankungen in der Schwangerschaft bedarf es einer individuellen Nutzen-Risiko-Abwägung zwischen der Gefährdung von Mutter und Kind durch eine unbehandelte psychische Störung ohne Medikamenteneinnahme und einer angemessenen Behandlung, die den Einsatz einer Medikation einschließen und die eine potenzielle Gefährdung des Kindes bedeuten kann. Unter Beachtung einiger Regeln und bei geeigneter Auswahl des Antipsychotikums kann das Risiko für das Neugeborene wie für die Mutter in der Schwangerschaft minimiert werden. Eine Entscheidung, wie mit der Medikation fortgefahren wird, kann aus den Ergebnissen dieser Arbeit nur indirekt getroffen werden.